Metabolic and Low-Grade Inflammation Risk in Young Adults with a History of Extrauterine Growth Restriction
Metadatos
Mostrar el registro completo del ítemAutor
Palomino-Fernández, Laura; Pastor Villaescusa, Belén; Velasco, Inmaculada; de la Cruz Rico, María; Roa, Juan; Gil Hernández, Ángel; Gil-Campos, MercedesEditorial
MDPI
Materia
extrauterine growth restriction inflammation adipokines
Fecha
2024-05-24Referencia bibliográfica
Palomino Hernández, L. et. al. Nutrients 2024, 16, 1608. [https://doi.org/10.3390/nu16111608]
Patrocinador
Modalidad Retos Consolidado. Dirección General de Investigación y Transferencia del Conocimiento. Consejería de Economía, Conocimiento, Empresas y Universidad; Junta de Andalucía, Spain (grant number PY18-1802); SPAOYEX (Sociedad de Pediatría de Andalucía Occidental y Extremadura) research grant 2022 editionResumen
Children with a history of extrauterine growth restriction (EUGR), later at prepubertal age,
exhibit an increased metabolic risk including risen insulin resistance and low-grade inflammation.
However, the progression of such metabolic changes after puberty and the lasting health implications
have not yet been investigated. The objective of this study was to ascertain whether young adults
with a history of EUGR faced increased vulnerability to metabolic disorders. A study was conducted
comparing a group of adults with a history of EUGR with a healthy reference group. A total
of 110 young adults (36 from the EUGR group and 74 from the control group) were included.
Anthropometric variables, blood pressure (BP), general biochemical parameters, plasma inflammatory
biomarkers, and adipokines were assessed. Compared to the reference group, the EUGR group had a
shorter height and body weight with higher lean mass and waist circumference, as well as a greater
percentage of individuals with high BP. In addition, EUGR patients had higher values of insulin,
HOMA-IR, nerve growth factor, and leptin, and lower levels of adiponectin and resistin. The present
study suggests that young adults with a history of EUGR present increased metabolic risk factors
therefore, clinical follow-up should be considered.